NEW BRUNSWICK, N.J., June 17, 2011 /PRNewswire-USNewswire/ -- Affineti Biologics has received a commitment of up to $500,000 from Foundation Venture Capital Group (FVCG) to advance its research in the development of therapeutic and diagnostic products based on new discoveries in oral biology and den
↧